The primary function of the surfactant is to decrease the surface tension at the air–liquid interface in the alveoli and distal bronchioles, to promote lung expansion during inspiration and to prevent ...

Researchers conducted a meta-analysis of 12 randomized controlled trials involving 2428 premature infants, comparing intratracheal budesonide plus pulmonary surfactant with pulmonary surfactant alone.

In a recent study posted to the bioRxiv* preprint server, researchers discuss the role of a surfactant-mediated inflammatory response employed by human lungs against the severe acute respiratory ...

WARRINGTON, Pa., Jan. 19, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCOD) has been notified that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent ...

Intratracheal administration of budesonide mixed with surfactant did not reduce the rates of bronchopulmonary dysplasia (BPD) or death compared with surfactant alone in extremely premature infants by ...

Usual interstitial pneumonia (UIP) is a risk factor for lung carcinogenesis. This study was performed to characterize mutagenesis and mutational target genes underlying lung carcinogenesis in patients ...

“Production of this drug requires high technological knowledge and has cost $4.5 million to $5 million,” IFIDA Head Mohamamdreza Shanehsaz said. Despite the challenges created by our country's enemies ...

New discovery on the causes of PAP lung disease can also offer solutions for treating obesity and heart disease. The research group has identified a genetic defect that causes the accumulation of ...